Champions Oncology (United States)
- World rank, all time
- #40,995 of 42,892
- Rank in United States
- #8,479 of 8,685
- Research works
- 146 ▲ 21% vs 2013–17
- Citations
- 803 5.5 per fractional work
- Top-10% rate
- 3.4% record average 16.5%
- Open access
- 36% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.3×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.3×
- Immunology and Microbiology 3.8×
- Medicine 2.2×
- Chemistry 1.5×
- Engineering 1.1×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Social Sciences 0.5×
- Neuroscience 0.5×
- Psychology 0.4×
- Earth and Planetary Sciences 0.4×
- Environmental Science 0.2×
- Arts and Humanities 0.2×
- Nursing 0.2×
- Health Professions 0.1×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.0×
- Mathematics 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at Champions Oncology (United States)?
Ranked on the composite score, Stefano Cairo and Gilad Silberberg lead among researchers whose main affiliation is Champions Oncology (United States).
- 1 Stefano Cairo United States · #517,185 worldwide 52 citations · 32 works
- 2 Gilad Silberberg United States · #1,539,140 worldwide 15 citations · 16 works
Which keywords describe research at Champions Oncology (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cell Culture, Regenerative Medicine, Microfluidic Devices, Bioprinting, Tissue Engineering, Cancer Immunotherapy and Cancer Stem Cells.
- Innate Immunity
- Acute Myeloid Leukemia
- Therapeutic Antibodies
- Mutational Signatures
- Cell-Free DNA
- Cell Death
- Immunity
- Tumor Heterogeneity
- Tumor Microenvironment
- Cancer Therapy
- Medical Imaging
- Feature Extraction
- Precision Medicine
- Cancer
- Prognostic Factors
- Tumor Regression
- Cancer Stem Cells
- Tissue Engineering
- Microfluidic Devices
- Cell Culture
- Immunotherapy
- Regenerative Medicine
- Bioprinting
- Cancer Immunotherapy
- Tumor Metastasis
- Chemotherapy
- CAR T Cells
- Chimeric Antigen Receptor
- Quantitative Analysis
- Gene Expression
- Nanoparticles
- Glycosylation
- Radiomics
- Tumor Targeting
- Targeted Therapy
- Cancer Genomics
- Fc Receptors
- Reactive Oxygen Species
- AML
- Monoclonal Antibody
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy6▲ 15×8 topics
- Cell Culture6▲ 93×2 topics
- Regenerative Medicine6▲ 40×2 topics
- Microfluidic Devices6▲ 84×2 topics
- Bioprinting6▲ 161×1 topic
- Tissue Engineering6▲ 16×1 topic
- Cancer Immunotherapy4▲ 42×2 topics
- Cancer Stem Cells4▲ 143×1 topic
- Tumor Metastasis4▲ 113×1 topic
- Tumor Regression4▲ 55×2 topics
- Chemotherapy3▲ 7.5×10 topics
- Prognostic Factors3▲ 12×4 topics
- CAR T Cells3▲ 66×1 topic
- Cancer3▲ 3.5×12 topics
- Chimeric Antigen Receptor3▲ 66×1 topic
- Precision Medicine3▲ 9.4×2 topics
- Quantitative Analysis3▲ 22×2 topics
- Feature Extraction2▲ 9.2×3 topics
- Gene Expression2▲ 7.0×9 topics
- Medical Imaging2▲ 7.9×2 topics
- Nanoparticles2▲ 3.2×4 topics
- Cancer Therapy2▲ 7.0×9 topics
- Glycosylation2▲ 36×2 topics
- Tumor Microenvironment2▲ 9.0×6 topics
- Radiomics2▲ 33×1 topic
- Tumor Heterogeneity2▲ 33×1 topic
- Tumor Targeting2▲ 21×3 topics
- Immunity2▲ 9.1×3 topics
- Targeted Therapy2▲ 16×2 topics
- Cell Death2▲ 14×5 topics
- Cancer Genomics2▲ 41×1 topic
- Cell-Free DNA2▲ 32×2 topics
- Fc Receptors2▲ 57×1 topic
- Mutational Signatures2▲ 41×1 topic
- Reactive Oxygen Species2▲ 7.8×3 topics
- Therapeutic Antibodies2▲ 45×1 topic
- AML2▲ 59×1 topic
- Acute Myeloid Leukemia2▲ 59×1 topic
- Monoclonal Antibody2▲ 54×2 topics
- Innate Immunity2▲ 8.6×4 topics
Which research topics does Champions Oncology (United States) publish most on?
By volume in 2022–2025: 3D Printing in Biomedical Research, Cancer Cells and Metastasis, CAR-T cell therapy research and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 3D Printing in Biomedical Research Biomedical Engineering 6 works
- 2 Cancer Cells and Metastasis Oncology 4 works
- 3 CAR-T cell therapy research Oncology 3 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 5 Cancer Genomics and Diagnostics Cancer Research 2 works
- 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 7 Acute Myeloid Leukemia Research Hematology 2 works
- 8 Linguistic, Cultural, and Literary Studies Sociology and Political Science 1 works
- 9 Military Technology and Strategies Aerospace Engineering 1 works
- 10 Legal and Regulatory Analysis Transportation 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Champions Oncology (United States)'s research output changed?
Output in 2018–2022 was 21% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hackensack
- Hackensack University Medical Center
- Takasago (United States)
- Tomorrows Children’s Fund
- Parent Project Muscular Dystrophy
- NorthEast Regional Epilepsy Group
- CJ Foundation for SIDS
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.